title: Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.
authors.forename: J
authors.initials: J
authors.lastname: Bryant
authors.forename: A
authors.initials: A
authors.lastname: Clegg
authors.forename: R
authors.initials: R
authors.lastname: Milne
mesh_terms: D000276:Adjuvants, Immunologic / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000191:economics / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics
chemical_list: D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a